MedStar Heart & Vascular Institute Hosts National Heart Valve Disease Awareness Day Flagship Event to Increase Awareness about Heart Valve Disease Washington, D.C. February 22, 2019 – In recognition of National Heart Valve Disease Awareness Day on Feb. 22, MedStar Heart & Vascular Institute hosted a flagship event at MedStar Washington Hospital Center to raise awareness about heart valve disease, which affects thousands of people in the Washington, D.C. area and millions nationwide. MedStar Heart & Vascular Institute physicians, along with U.S. Surgeon General Vice Admiral Jerome M. Adams, MD, MPH and WebMD Chief Medical Officer John Whyte, MD, MPH,…

Read More

Washington, D.C., December 4, 2018  – The FDA has recently approved an investigational new drug clinical trial that will start shortly at MedStar Heart & Vascular Institute. The trial, called STEMVAD, is sponsored by MedStar Heart, in partnership with CardioCell, to determine whether stem cell therapy improves myocardial function in patients with severe heart failure—severe enough to require the implantation of a left ventricular assist device, or LVAD. The trial will use CardioCell’s proprietary mesenchymal stem cells (MSCs), and will pioneer the use of a novel delivery strategy, deriving from a new understanding of the causes of progressive heart failure…

Read More

Patients Undergoing Transcatheter Aortic Valve Replacement Showed No Deaths or Disabling Strokes within 30 days of Undergoing Less Invasive Procedure

Read More